ARTELO BIOSCIENCES, INC. (ARTL) Operating cash flow 2016–2025
ARTELO BIOSCIENCES, INC. (ARTL) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$8.5MFY2025 · since FY2016: -$18,489 → -$8.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$8.5M | -2.0% |
| FY2024 | -$8.3M | -1.7% |
| FY2023 | -$8.2M | -2.5% |
| FY2022 | -$8.0M | -30.4% |
| FY2021 | -$6.1M | -41.3% |
| FY2020 | -$4.3M | -55.7% |
| FY2019 | -$2.8M | -73.5% |
| FY2018 | -$1.6M | -642.6% |
| FY2017 | -$216,821 | -1072.7% |
| FY2016 | -$18,489 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ARTL financial trends
ARTL RevenueARTL Net incomeARTL Net marginARTL Gross profitARTL Gross marginARTL Operating incomeARTL Operating marginARTL Free cash flowARTL Capital expendituresARTL Return on equityARTL Stock buybacksARTL Dividends paidARTL Total assetsARTL Total liabilitiesARTL Shareholders’ equityARTL overview →